Introduction to Protein Sequencing and Mass Spectrometry

What is Protein Sequencing?

Protein sequencing is the analytical process of determining the primary structure of a protein, which refers to the linear order of its constituent amino acids. This sequence dictates the protein's three-dimensional structure, function, and interactions within a biological system. Accurate protein sequencing is critical for:

• Identifying novel proteins.
• Confirming the identity of recombinant proteins.
• Detecting mutations or sequence variants.
• Characterizing post-translational modifications (PTMs).
• Understanding protein evolution and relationships.

What is Mass Spectrometry (MS)?

Mass Spectrometry is an analytical technique that measures the mass-to-charge ratio (m/z) of ions. It works by ionizing chemical compounds to generate charged molecules or molecule fragments and measuring their m/z ratios. The resulting spectrum provides information about the molecular weight, elemental composition, and structural characteristics of the sample. A typical mass spectrometer consists of three main components:

• Ion Source: Converts sample molecules into gas-phase ions.
• Mass Analyzer: Separates ions based on their m/z ratio.
• Detector: Measures the abundance of separated ions.

Why Mass Spectrometry for Protein Sequencing?

The advent of "soft" ionization techniques in the late 1980s, such as Electrospray Ionization (ESI) and Matrix-Assisted Laser Desorption/Ionization (MALDI), enabled the transfer of large, fragile biomolecules like proteins and peptides into the gas phase without significant degradation. This breakthrough paved the way for MS to become the cornerstone of modern proteomics.

• Advantages over Traditional Methods

Prior to MS, Edman degradation was the gold standard for protein sequencing. While effective for short peptides, it suffered from significant limitations.

Table 1. Comparison of Edman Degradation and Mass Spectrometry for Protein Sequencing

• Broad Applications in Proteomics

MS-based protein sequencing is central to proteomics, the large-scale study of proteins. Its versatility allows for:

• Protein Identification: Rapidly identifying proteins from complex biological samples.
• Quantitative Proteomics: Measuring protein abundance changes across different biological states.
• PTM Analysis: Characterizing modifications that regulate protein function.
• Protein-Protein Interactions: Elucidating protein networks.
• Biomarker Discovery: Identifying disease-specific protein signatures.

Fundamentals of Mass Spectrometry in Protein Analysis

The power of MS in protein analysis stems from its ability to precisely measure molecular masses and, critically, to fragment molecules and analyze the masses of the resulting fragments.

Key Ionization Techniques

Two primary ionization methods are dominant in protein and peptide MS:

• Electrospray Ionization (ESI)

• Principle: A solution containing the analyte is sprayed through a fine needle at high voltage, creating charged droplets. Solvent evaporation and Coulombic repulsion lead to the formation of gas-phase ions, often multiply charged.
• Advantages: Excellent for coupling with liquid chromatography (LC-MS/MS), generates multiply charged ions simplifying the analysis of large molecules, and is well-suited for polar and thermally labile compounds.
• Applications: Widely used in bottom-up proteomics.

• Matrix-Assisted Laser Desorption/Ionization (MALDI)

• Principle: The analyte is co-crystallized with a large excess of a UV-absorbing matrix compound. A laser pulse desorbs and ionizes the matrix, which in turn transfers charge to the analyte, typically producing singly charged ions.
• Advantages: High sensitivity, tolerant to salts and buffers, ideal for high-throughput analysis (e.g., MALDI-TOF), and generates predominantly singly charged ions, simplifying spectra.
• Applications: Protein identification, peptide mass fingerprinting, and imaging mass spectrometry.

Tandem Mass Spectrometry (MS/MS)

Tandem Mass Spectrometry, or MS/MS, is the cornerstone of protein sequencing by MS. It involves multiple stages of mass analysis, allowing for the fragmentation of selected precursor ions and the subsequent mass analysis of these fragment ions.

• Principles of Fragmentation

In MS/MS, a precursor ion (e.g., a peptide ion) is first selected in the mass analyzer. This selected ion is then subjected to controlled fragmentation in a collision cell. The fragmentation breaks specific bonds within the molecule, generating a series of product ions. For peptides, fragmentation typically occurs along the peptide backbone, yielding characteristic fragment ions that contain sequence information.

The nomenclature for peptide fragment ions is standardized:

• b-ions: Contain the N-terminus.
• y-ions: Contain the C-terminus.
• Other less common ions include a-ions, x-ions, z-ions, etc.

The mass difference between consecutive b-ions or y-ions corresponds to the mass of an individual amino acid residue, allowing for de novo sequence determination.

• Collision-Induced Dissociation (CID)

Collision-Induced Dissociation (CID), also known as Collisionally Activated Dissociation (CAD), is the most common fragmentation technique used in proteomics.

• Principle: Selected precursor ions are accelerated into a collision cell containing an inert gas (e.g., argon, nitrogen). Collisions between the ions and the gas molecules transfer kinetic energy into internal energy, leading to vibrational excitation and ultimately bond cleavage.
• Characteristics: CID typically produces b- and y-ions, which are highly informative for peptide sequencing. It is effective for peptides with multiple charge states.
• Limitations: Can be less effective for very large peptides or those with extensive PTMs, and some labile PTMs might be lost during fragmentation.

Other fragmentation techniques include Electron Capture Dissociation (ECD), Electron Transfer Dissociation (ETD), and Higher-Energy Collisional Dissociation (HCD), each offering unique advantages for specific applications, particularly for PTM analysis and top-down proteomics.

Methodologies for Protein Sequencing by MS

Different strategies are employed for protein sequencing by MS, each with its own strengths and applications.

Bottom-Up Proteomics (MS Protein Sequencing)

Bottom-up proteomics is the most widely adopted approach for protein identification and characterization. It involves digesting proteins into smaller, more manageable peptides before MS analysis.

• Protein Digestion and Peptide Generation

• Denaturation and Reduction/Alkylation: Proteins are first denatured to unfold them and expose cleavage sites. Disulfide bonds are reduced (e.g., with DTT) and then alkylated (e.g., with iodoacetamide) to prevent re-formation.
• Enzymatic Digestion: The denatured proteins are then enzymatically digested into peptides. Trypsin is the most commonly used enzyme due to its high specificity, cleaving at the C-terminal side of lysine (K) and arginine (R) residues (unless followed by proline). This produces peptides typically ranging from 5 to 30 amino acids, ideal for MS/MS analysis. Other enzymes like Lys-C, Glu-C, or chymotrypsin can also be used for specific purposes or to generate overlapping peptides.

Fig. 1 Results of sequence inference accuracy comparison on CPTAC.¹

• LC-MS/MS for Peptide Sequencing

The resulting peptide mixture is highly complex and requires separation before MS analysis.

• Liquid Chromatography (LC): Peptides are typically separated by reversed-phase liquid chromatography (RPLC) based on their hydrophobicity. The LC system is directly coupled to the mass spectrometer.
• MS/MS Analysis: As peptides elute from the LC column, they are ionized (typically by ESI) and introduced into the mass spectrometer. In a data-dependent acquisition (DDA) workflow, the mass spectrometer performs a full MS scan to identify the most abundant precursor ions. These precursor ions are then individually selected, fragmented (e.g., by CID or HCD), and their product ion spectra are acquired in subsequent MS/MS scans. This process is repeated for as many peptides as possible within the LC run.

• Database Searching for Protein Identification

The acquired MS/MS spectra contain the sequence information of the fragmented peptides. This information is then used for protein identification:

• Spectrum Matching: The experimental MS/MS spectra are compared against theoretical spectra generated from a protein sequence database. Software algorithms search for the best match between experimental and theoretical fragment ion patterns.
• Protein Inference: Based on the identified peptides, proteins are inferred. Multiple unique peptides mapping to a single protein provide high confidence in the protein identification.
• Scoring and Validation: Matches are scored based on statistical significance, and false discovery rates (FDR) are calculated to ensure the reliability of identifications.

Top-Down Proteomics

Top-down proteomics involves the analysis of intact proteins without prior enzymatic digestion.

• Principle: Whole proteins are directly introduced into the mass spectrometer, ionized, and then fragmented (e.g., using ECD, ETD, or HCD) to generate fragment ions from the entire protein.
• Advantages: Provides comprehensive sequence coverage, allows for the direct characterization of PTMs and sequence variants across the entire protein, and avoids the "peptidecentric" view of bottom-up approaches.
• Challenges: Requires high-resolution mass spectrometers to resolve complex spectra of large, multiply charged protein fragments, and sophisticated bioinformatics tools for data analysis.
• Applications: Characterization of proteoforms, analysis of therapeutic proteins, and identification of sequence truncations.

Middle-Down Proteomics

Middle-down proteomics is an intermediate approach where proteins are partially digested into larger peptide fragments (typically 10-50 kDa) before MS/MS analysis.

• Principle: Proteins are digested with less specific enzymes or under controlled conditions to yield larger fragments. These fragments are then subjected to high-resolution MS/MS.
• Advantages: Bridges the gap between bottom-up (good for peptides, loses global PTM information) and top-down (difficult for large proteins, high complexity). Offers better sequence coverage than bottom-up for large proteins and simplifies fragmentation compared to top-down.
• Applications: Characterization of large protein domains, analysis of PTMs on larger segments, and antibody characterization.

De Novo Protein Sequencing

De novo protein sequencing is the process of determining the amino acid sequence of a peptide or protein directly from its MS/MS spectrum without prior knowledge of its sequence or a protein database.

• Principle: Relies on interpreting the mass differences between consecutive fragment ions (b-ions and y-ions) in the MS/MS spectrum. Each mass difference corresponds to the mass of a specific amino acid residue.
• Applications: Essential for sequencing novel proteins, identifying sequence variants not present in databases, characterizing immunoglobulins (e.g., antibody sequencing), and validating database search results.
• Challenges: Requires high-quality MS/MS spectra, expertise in spectral interpretation, and sophisticated bioinformatics algorithms to handle ambiguities and generate accurate sequences.

Diverse Applications of MS-Based Protein Sequencing

The capabilities of MS-based protein sequencing extend across numerous biological and biotechnological applications.

Protein Identification and Characterization

The most fundamental application is the identification of proteins present in a sample. By matching experimental peptide sequences to known protein sequences in databases, researchers can rapidly identify thousands of proteins from complex biological matrices, such as cell lysates, tissues, or biofluids. This is crucial for:

• Discovery Proteomics: Identifying all proteins expressed under specific conditions.
• Target Validation: Confirming the presence and identity of therapeutic targets.
• Bioprocess Monitoring: Ensuring the identity and purity of recombinant proteins during production.

Analysis of Post-Translational Modifications (PTMs)

PTMs are covalent modifications to proteins that occur after translation, significantly expanding the functional diversity of the proteome. MS is indispensable for identifying and localizing PTMs.

• Identification of Glycan Sites: Glycosylation, the enzymatic addition of glycans (carbohydrate chains) to proteins, is a critical PTM affecting protein folding, stability, and cell-cell recognition. MS can identify glycosylation sites and characterize the attached glycan structures.
• Phosphorylation Analysis: Phosphorylation, the reversible addition of a phosphate group, is a key regulatory mechanism in virtually all cellular processes. MS is the primary tool for identifying phosphorylation sites and quantifying changes in phosphorylation status.

Protein Sequencing and De Novo Antibody Sequencing

Antibodies are complex glycoproteins with critical roles in immunity and as therapeutic agents. Accurate sequencing of antibody variable regions (Fab and Fc) is crucial for drug development, intellectual property, and biosimilar characterization.

• De Novo Sequencing: For novel antibodies or those with unknown sequences, de novo sequencing by MS is essential to determine the heavy and light chain variable regions. This often involves a combination of bottom-up and middle-down approaches to achieve comprehensive coverage.
• Sequence Confirmation: For known antibodies, MS provides a robust method for confirming the sequence, detecting any sequence variants, and characterizing PTMs such as glycosylation, oxidation, and deamidation, which can impact antibody efficacy and stability.

Elucidation of Protein Structure, Function, and Interactions

While MS primarily provides primary sequence information, it can also contribute to understanding higher-order protein structure and function.

• Hydrogen-Deuterium Exchange (HDX-MS): Provides insights into protein dynamics, conformational changes, and protein-ligand binding by measuring the exchange rate of backbone amide hydrogens with deuterium.
• Cross-linking Mass Spectrometry (XL-MS): Identifies spatially proximal residues within a protein or between interacting proteins, providing distance constraints that aid in structural modeling and mapping protein-protein interaction interfaces.

Quantitative Proteomics

Quantitative proteomics aims to measure the relative or absolute abundance of proteins in different biological samples. MS-based methods are highly effective for this.

From fundamental protein identification to intricate PTM analysis, antibody characterization, and quantitative proteomics, MS continues to drive advancements in our understanding of the proteome and its profound impact on health and disease. At Creative Biolabs, we offer de novo antibody sequencing and de novo protein sequencing services, powered by our propriety DASS (Database Assisted Shotgun Sequencing) technology to meet the diverse protein research needs of our clients, driving innovation and advancement in the field of biomedical science.

Learn more about Creative Biolabs’ de novo antibody sequencing services:

• De Novo Sequencing Services
• De Novo Human/Humanized Antibody Sequencing Service
• De Novo Biosimilar Monoclonal Antibody Sequencing Service
• De Novo Single Domain Antibody (SdAb) Sequencing Service
• De Novo Rodent Antibody Sequencing Service
• De Novo Rabbit Antibody Sequencing Service
• De Novo Chicken IgY Sequencing Service
• De Novo T Cell Receptor (TCR) Sequencing Service
• Hybridoma Sequencing Service

Loading case studies...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.